Classification Nuance. The OpenFDA dataset, which draws from the Structured Product Labeling (SPL) files, often includes multiple classification fields, and the specific string "Phosphate Binder [EPC]" may only be assigned to a single product. The other drugs are likely classified using: More Specific Classes: Many of those drugs (like sevelamer, ferric citrate, etc.) may be classified by their specific mechanism or chemical group, which also acts as a phosphate binder. Example: A drug might be classified as "Iron-Containing Compound [EPC]" or "Aluminum-Containing Compound [EPC]" instead of the more general "Phosphate Binder [EPC]". Different Classification Fields: The NDC data contains several classification fields. You might be checking the Established Pharmacological Class (pharm_class_epc), but the other drugs might be listed under: Mechanism of Action (pharm_class_moa), Physiological Effect (pharm_class_pe)
  Home  

Enter a class name or drug name above to search the database.

beta3-Adrenergic Agonist [EPC]

NDC Number Brand Name Generic Name Manufacturer Dosage Form DEA Sch. Marketing Start Date
0469-2601 Myrbetriq mirabegron Astellas Pharma US, Inc. TABLET, FILM COATED, EXTENDED RELEASE 2012-06-28
0469-2602 Myrbetriq mirabegron Astellas Pharma US, Inc. TABLET, FILM COATED, EXTENDED RELEASE 2012-06-28
0469-5020 Myrbetriq mirabegron Astellas Pharma US, Inc. GRANULE, FOR SUSPENSION, EXTENDED RELEASE 2021-03-25
55154-8712 Myrbetriq mirabegron Cardinal Health 107, LLC TABLET, FILM COATED, EXTENDED RELEASE 2012-06-28
55154-8713 Myrbetriq mirabegron Cardinal Health 107, LLC TABLET, FILM COATED, EXTENDED RELEASE 2012-06-28
68180-151 MIRABEGRON mirabegron Lupin Pharmaceuticals, Inc. TABLET, FILM COATED, EXTENDED RELEASE 2024-04-19
68180-152 MIRABEGRON mirabegron Lupin Pharmaceuticals, Inc. TABLET, FILM COATED, EXTENDED RELEASE 2024-09-03
70518-2435 Myrbetriq mirabegron REMEDYREPACK INC. TABLET, FILM COATED, EXTENDED RELEASE 2019-11-19
70518-4304 Mirabegron Mirabegron REMEDYREPACK INC. TABLET, EXTENDED RELEASE 2025-03-07
70710-1159 Mirabegron Mirabegron Zydus Pharmaceuticals (USA) Inc. TABLET, EXTENDED RELEASE 2024-01-23
70710-1160 Mirabegron Mirabegron Zydus Pharmaceuticals (USA) Inc. TABLET, EXTENDED RELEASE 2024-01-23
70771-1752 Mirabegron Mirabegron Zydus Lifesciences Limited TABLET, EXTENDED RELEASE 2024-01-23
70771-1753 Mirabegron Mirabegron Zydus Lifesciences Limited TABLET, EXTENDED RELEASE 2024-01-23
71335-2807 MIRABEGRON mirabegron Bryant Ranch Prepack TABLET, FILM COATED, EXTENDED RELEASE 2024-04-19
71335-2808 MIRABEGRON mirabegron Bryant Ranch Prepack TABLET, FILM COATED, EXTENDED RELEASE 2024-09-03
71335-2809 MIRABEGRON mirabegron Bryant Ranch Prepack TABLET, FILM COATED, EXTENDED RELEASE 2024-04-19
71335-2810 MIRABEGRON mirabegron Bryant Ranch Prepack TABLET, FILM COATED, EXTENDED RELEASE 2024-09-03
73336-075 GEMTESA vibegron Sumitomo Pharma America, Inc. TABLET, FILM COATED 2020-12-29



 [EPC] Established Pharmacological Classification 

Loading full table content...